Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies.

Elevated Anti-Müllerian Hormone Levels in Newborns of Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis Based on Observational Studies.
复制标题

DOI:
10.1007/s43032-021-00652-w
复制
发表时间:
2022-01
期刊:
Reproductive sciences (Thousand Oaks, Calif.)
影响因子:
--
通讯作者:
Xu L
Xu L
中科院分区:
其他
文献类型:
--
作者:
Zhou S;Lu D;Wen S;Sheng Y;Kang D;Xu L

文献摘要

参考文献

被引文献

相似文献

We performed this updated systematic review and meta-analysis to evaluate anti-Müllerian hormone levels (AMH) in newborns of mothers with polycystic ovary syndrome (PCOS) compared with healthy controls. A search of the literature was conducted in the PubMed, MEDLINE, EMBASE, Cochrane Library, CBM, CNKI, WANFANG, and VIP for articles to assess AMH levels in offspring of PCOS and non-PCOS mothers irrespective of language. These databases were searched from their inception to December 7, 2020. The quality of studies was assessed using the Newcastle-Ottawa Scale (NOS) scoring system. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were adopted to calculate the overall estimates with random-effects models. A total of 6 studies with 846 participants were included. The pooled analysis found an increased AMH level in the umbilical cord blood in newborns of PCOS mothers (SMD =0.62, 95% CI [0.28, 0.95]). Subgroup analyses revealed an elevation of AMH concentrations in female neonates, neonates born to American and Asian PCOS mothers. In addition, higher AMH levels were also found in studies diagnosed by the National Institute of Health (NIH) criteria, maternal clinical/biochemical hyperandrogenism, or maternal body mass index (BMI) >30 kg/m2. Meta-regression analysis suggested that diagnostic criterion contributed mostly to the high heterogeneity. We demonstrated that AMH levels in neonates born to PCOS mothers were essentially higher, which indicates that AMH may act as an enigmatic role in the pathogenesis of PCOS which inhibits folliculogenesis in the fetal stage.
DOI: 10.1016/j.fertnstert.2013.05.023
发表时间: 2013-07
影响因子: 6.7
作者:
Abbott, David H.;Bacha, Fida
通讯作者: Bacha, Fida
DOI: 10.1080/19396368.2018.1537385
发表时间: 2019-03-04
影响因子: 2.4
作者:
Detti, Laura;Christiansen, Mary E.;Tobiasz, Ana M.
通讯作者: Tobiasz, Ana M.
DOI: 10.1186/s13048-019-0583-4
发表时间: 2019-11-17
影响因子: 4
作者:
Far, Faezeh Tadaion;Sadatmahalleh, Shahideh Jahanian;Kazemnejad, Anoshirvan
通讯作者: Kazemnejad, Anoshirvan
DOI: 10.1111/j.1365-2265.2009.03614.x
发表时间: 2010-01-01
影响因子: 3.2
作者:
Park, Hyun T.;Cho, Geum J.;Kim, Tak
通讯作者: Kim, Tak
DOI: 10.1210/en.2002-220965
发表时间: 2003-04-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Birch, RA;Padmanabhan, V;Robinson, JE
通讯作者: Robinson, JE